N-{3-[(2-chloro-4-pyrimidinyl)acetyl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide
![BK62J0 | 1195768-20-7 | N-{3-[(2-chloro-4-pyrimidinyl)acetyl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide](https://qncdn.chemcd.cn/alchemypharm/1195768-20-7.png "BK62J0 | 1195768-20-7 | N-{3-[(2-chloro-4-pyrimidinyl)acetyl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide")
Catalog No.: BK62J0
CAS.RN：1195768-20-7
Molecular Formula: C18H11ClF3N3O3S
Molecular Weight: 441.81 g/mol
Purity: NLT 98%
Synonyms:
Intermediates of Dabrafenib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA6Q63 | Dabrafenib API | 1195765-45-7 |
| BK77DN | Dabrafenib Mesylate | 1195768-06-9 |
| BK422U | 2,2,2-Trimethylthioacetamide | 630-22-8 |
| BK38X9 | Methyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoate | 1195768-19-4 |
| BK62J0 | N-{3-[(2-chloro-4-pyrimidinyl)acetyl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide | 1195768-20-7 |
| BK2G78 | N-[3-[2-Tert-butyl-5-(2-chloropyrimidin-4-yl)-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide | 1195768-23-0 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
